Tapewire

NYSE · USD

A

AGILENT TECHNOLOGIES, INC.

Export transactions ↓
Tapewire entity
3062
SEC CIK
0001090872
Parsed reports
728

Last 12 months

Inside the activity.

0 purchase rows · 6 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202501
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202601
Jun 202600
Jul 202600
Aug 202600
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 18, 2018 Filed May 23, 2018 23:02 UTC
Raha Samraat S.Sr. Vice President
Tax withholdingCommon Stock 539 $61.94 $33,385.66
Disclosure

SEC source: 0001127602-18-018595 · form4.xml · nonDerivative · entry 2

Raha Samraat S. · CIK 0001738340 · Sr. Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,946.729

F2 · shares: The reporting person surrendered shares to Agilent Technologies, Inc. to satisfy tax withholding obligations on restricted stock units in accordance with Rule 16b-3.

Read SEC document
May 15, 2018 Filed May 23, 2018 23:05 UTC
Thaysen JacobSr Vice President
GrantCommon Stock 2,116 $62.50 $132,250.00
Disclosure

SEC source: 0001127602-18-018598 · form4.xml · nonDerivative · entry 1

Thaysen Jacob · CIK 0001625263 · Sr Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,575

F1 · shares: Restricted Stock Units granted under the Agilent Technologies, Inc. 2018 Stock Plan, in compliance with Rule 16b-3. The restricted stock units vest in four equal annual installments beginning on May 15, 2019.

Read SEC document
May 15, 2018 Filed May 23, 2018 23:02 UTC
Raha Samraat S.Sr. Vice President
GrantCommon Stock 2,605 $62.50 $162,812.50
Disclosure

SEC source: 0001127602-18-018595 · form4.xml · nonDerivative · entry 1

Raha Samraat S. · CIK 0001738340 · Sr. Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,485.729

F1 · shares: Restricted Stock Units granted under the Agilent Technologies, Inc. 2018 Stock Plan, in compliance with Rule 16b-3. The restricted stock units vest in four equal annual installments beginning on May 15, 2019.

Read SEC document
March 29, 2018 Filed Mar 29, 2018 22:29 UTC
Kaltenbach PatrickSr Vice President
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 4,000 $0.00 Strike: $41.26 $0.00
Disclosure

SEC source: 0001127602-18-013048 · form4.xml · derivative · entry 3

Kaltenbach Patrick · CIK 0001625775 · Sr Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,292

Underlying: Common Stock · 4,000 shares

Expires 2024-11-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. Stock Plan, in compliance with Rule 16b-3.

F2 · derivative.exercise_date: The option is exercisable in four equal annual installments beginning on the first anniversary of the date of the grant. The first vesting date is stated.

Read SEC document
March 29, 2018 Filed Mar 29, 2018 22:29 UTC
Kaltenbach PatrickSr Vice President
SaleCommon Stock 4,000 $67.28 $269,112.80
Disclosure

SEC source: 0001127602-18-013048 · form4.xml · nonDerivative · entry 2

Kaltenbach Patrick · CIK 0001625775 · Sr Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,547.467

Read SEC document
March 29, 2018 Filed Mar 29, 2018 22:29 UTC
Kaltenbach PatrickSr Vice President
Exercise / conversionCommon Stock 4,000 $41.26 $165,040.00
Disclosure

SEC source: 0001127602-18-013048 · form4.xml · nonDerivative · entry 1

Kaltenbach Patrick · CIK 0001625775 · Sr Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,547.467

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 27, 2018 Filed Mar 28, 2018 18:41 UTC
FIELDS HEIDIDirector
Exercise / conversionNon-Employee Director Stock Option (right to buy) · Derivative 5,000 $0.00 Strike: $13.89 $0.00
Disclosure

SEC source: 0001127602-18-012907 · form4.xml · derivative · entry 4

FIELDS HEIDI · CIK 0001014330 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,482

Underlying: Common Stock · 5,000 shares

Expires 2018-11-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. 1999 Non-Employee Director Stock Plan.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
March 27, 2018 Filed Mar 28, 2018 18:41 UTC
FIELDS HEIDIDirector
SaleCommon Stock 5,000 $68.09 $340,450.00
Disclosure

SEC source: 0001127602-18-012907 · form4.xml · nonDerivative · entry 2

FIELDS HEIDI · CIK 0001014330 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,562.752

F1 · price: The weighted average sale price was $68.09 with a range of $68.081 and $68.09.

Read SEC document
March 27, 2018 Filed Mar 28, 2018 18:41 UTC
FIELDS HEIDIDirector
Exercise / conversionCommon Stock 5,000 $13.89 $69,450.00
Disclosure

SEC source: 0001127602-18-012907 · form4.xml · nonDerivative · entry 1

FIELDS HEIDI · CIK 0001014330 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,562.752

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 22, 2018 Filed Mar 23, 2018 22:34 UTC
FIELDS HEIDIDirector
GrantCommon Stock 2,876 $67.47 $194,043.72
Disclosure

SEC source: 0001127602-18-012678 · form4.xml · nonDerivative · entry 1

FIELDS HEIDI · CIK 0001014330 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Living Trust

Disclosed balance after: 12,488

F1 · shares: Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant.

F2 · balance_after: 321.210 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan.

Read SEC document
March 22, 2018 Filed Mar 23, 2018 22:42 UTC Tax withholdingCommon Stock 863 $6,747.00 $5,822,661.00
Disclosure

SEC source: 0001127602-18-012683 · form4.xml · nonDerivative · entry 2

KOH BOON HWEE · CIK 0001235113 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,063.316

F3 · shares: The reporting person surrendered 863 shares to Agilent Technologies, Inc. to satisfy tax liability on the vesting of restricted stock units in accordance with rules 16b-3.

Read SEC document
March 22, 2018 Filed Mar 23, 2018 22:42 UTC GrantCommon Stock 2,876 $67.47 $194,043.72
Disclosure

SEC source: 0001127602-18-012683 · form4.xml · nonDerivative · entry 1

KOH BOON HWEE · CIK 0001235113 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,926.316

F1 · shares: Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant.

F2 · balance_after: 49.707 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan.

Read SEC document
March 22, 2018 Filed Mar 23, 2018 22:37 UTC
WILSON DOW RDirector
GrantCommon Stock 2,876 $67.47 $194,043.72
Disclosure

SEC source: 0001127602-18-012681 · form4.xml · nonDerivative · entry 1

WILSON DOW R · CIK 0001313996 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,876

F1 · shares: Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. The reporting person has elected to defer receipt of these shares of common stock.

Read SEC document
March 22, 2018 Filed Mar 23, 2018 22:36 UTC GrantCommon Stock 1,438.063 $67.47 $97,026.11
Disclosure

SEC source: 0001127602-18-012680 · form4.xml · nonDerivative · entry 2

SCANGOS GEORGE A · CIK 0001202102 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,573.856

F3 · shares: Shares of the Company's common stock held in a deferral account pursuant to the Agilent Technologies, Inc. 2005 Deferred Compensation Plan for Non-Employee Directors that vest in 25% quarterly increments, with the first date of vesting being the date of grant.

Read SEC document
March 22, 2018 Filed Mar 23, 2018 22:36 UTC GrantCommon Stock 2,876 $67.47 $194,043.72
Disclosure

SEC source: 0001127602-18-012680 · form4.xml · nonDerivative · entry 1

SCANGOS GEORGE A · CIK 0001202102 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,135.793

F1 · shares: Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. The reporting person has elected to defer these shares of common stock.

F2 · balance_after: 6.877 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan.

Read SEC document
March 22, 2018 Filed Mar 23, 2018 22:33 UTC GrantCommon Stock 1,438.063 $67.47 $97,026.11
Disclosure

SEC source: 0001127602-18-012676 · form4.xml · nonDerivative · entry 3

Yamada Tadataka · CIK 0001402530 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,647.084

F4 · shares: Shares of Agilent Technologies, Inc. common stock held in a deferral account pursuant to the Agilent Technologies, Inc. 2005 Deferred Compensation Plan for Non-Employee Directors that vest quarterly in 25% increments, with the first vesting on the date of grant.

Read SEC document
March 22, 2018 Filed Mar 23, 2018 22:33 UTC GrantCommon Stock 287.613 $67.47 $19,405.25
Disclosure

SEC source: 0001127602-18-012676 · form4.xml · nonDerivative · entry 2

Yamada Tadataka · CIK 0001402530 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,209.021

F3 · shares: Shares of the Company's common stock held in a deferral account pursuant to the Agilent Technologies, Inc. 2005 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
March 22, 2018 Filed Mar 23, 2018 22:33 UTC GrantCommon Stock 2,876 $67.47 $194,043.72
Disclosure

SEC source: 0001127602-18-012676 · form4.xml · nonDerivative · entry 1

Yamada Tadataka · CIK 0001402530 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,921.408

F1 · shares: Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. The reporting person has elected to defer these shares of common stock.

F2 · balance_after: 267.800 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan

Read SEC document
March 22, 2018 Filed Mar 23, 2018 22:31 UTC
Rataj Sue H.Director
GrantCommon Stock 2,876 $67.47 $194,043.72
Disclosure

SEC source: 0001127602-18-012674 · form4.xml · nonDerivative · entry 1

Rataj Sue H. · CIK 0001529531 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,736

F1 · shares: Shares acquired from an award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant.

Read SEC document
March 22, 2018 Filed Mar 23, 2018 22:28 UTC
CLARK PAUL NDirector
GrantCommon Stock 2,876 $67.47 $194,043.72
Disclosure

SEC source: 0001127602-18-012672 · form4.xml · nonDerivative · entry 1

CLARK PAUL N · CIK 0001222248 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,929.337

F1 · shares: Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant.

F2 · balance_after: 533.417 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan

Read SEC document
March 22, 2018 Filed Mar 23, 2018 22:27 UTC GrantCommon Stock 1,438.063 $67.47 $97,026.11
Disclosure

SEC source: 0001127602-18-012670 · form4.xml · nonDerivative · entry 2

Bishop Hans Edgar · CIK 0001480212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,521.748

F3 · shares: Shares of Agilent Technologies, Inc. common stock held in a deferral account pursuant to the Agilent Technologies, Inc. 2005 Deferred Compensation Plan for Non-Employee Directors that vest quarterly in 25% increments, with the first vesting on the date of grant.

Read SEC document
March 22, 2018 Filed Mar 23, 2018 22:27 UTC GrantCommon Stock 2,876 $67.47 $194,043.72
Disclosure

SEC source: 0001127602-18-012670 · form4.xml · nonDerivative · entry 1

Bishop Hans Edgar · CIK 0001480212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,083.685

F1 · shares: Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. The reporting person has elected to defer receipt of these shares of common stock.

F2 · balance_after: 8.865 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan.

Read SEC document
March 22, 2018 Filed Mar 23, 2018 22:25 UTC GrantCommon Stock 71.903 $67.47 $4,851.30
Disclosure

SEC source: 0001127602-18-012668 · form4.xml · nonDerivative · entry 3

Podolsky Daniel K · CIK 0001644558 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,407.479

F4 · shares: Shares of the Company's common stock held in a deferral account pursuant to the Agilent Technologies, Inc. 2005 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
March 22, 2018 Filed Mar 23, 2018 22:25 UTC GrantCommon Stock 719.031 $67.47 $48,513.02
Disclosure

SEC source: 0001127602-18-012668 · form4.xml · nonDerivative · entry 2

Podolsky Daniel K · CIK 0001644558 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,335.576

F3 · shares: Shares of the Company's common stock held in a deferral account pursuant to the Agilent Technologies, Inc. 2005 Deferred Compensation Plan for Non-Employee Directors that vest quarterly in 25% increments, with the first date of vesting being the date of grant.

Read SEC document
March 22, 2018 Filed Mar 23, 2018 22:25 UTC GrantCommon Stock 2,876 $67.47 $194,043.72
Disclosure

SEC source: 0001127602-18-012668 · form4.xml · nonDerivative · entry 1

Podolsky Daniel K · CIK 0001644558 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,616.545

F1 · shares: Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. The reporting person has elected to defer these shares of common stock.

F2 · balance_after: 125.088 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan.

Read SEC document
March 13, 2018 Filed Mar 14, 2018 20:40 UTC
Gonsalves RodneyV.P., Corporate Controller
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 6,825 $0.00 Strike: $39.12 $0.00
Disclosure

SEC source: 0001127602-18-011569 · form4.xml · derivative · entry 3

Gonsalves Rodney · CIK 0001642192 · V.P., Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,000

Underlying: Common Stock · 6,825 shares

Expires 2023-11-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. Stock Plan, in compliance with Rule 16b-3.

F4 · derivative.exercise_date: The option is fully vested and exercisable

Read SEC document
March 13, 2018 Filed Mar 14, 2018 20:40 UTC
Gonsalves RodneyV.P., Corporate Controller
SaleCommon Stock 6,825 $71.23 $486,144.75
Disclosure

SEC source: 0001127602-18-011569 · form4.xml · nonDerivative · entry 2

Gonsalves Rodney · CIK 0001642192 · V.P., Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,424.8411

F2 · price: The weighted average sale price is $71.23 with a range of $71.17 - $71.25.

Read SEC document
March 13, 2018 Filed Mar 14, 2018 20:40 UTC
Gonsalves RodneyV.P., Corporate Controller
Exercise / conversionCommon Stock 6,825 $39.12 $266,994.00
Disclosure

SEC source: 0001127602-18-011569 · form4.xml · nonDerivative · entry 1

Gonsalves Rodney · CIK 0001642192 · V.P., Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,249.8411

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: 14.686 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan.

Read SEC document
March 13, 2018 Filed Mar 14, 2018 20:37 UTC
Doak MarkSr. Vice President
SaleCommon Stock 2,441 $71.00 $173,311.00
Disclosure

SEC source: 0001127602-18-011565 · form4.xml · nonDerivative · entry 1

Doak Mark · CIK 0001619051 · Sr. Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,533.212

F1 · balance_after: Includes 16.455 Shares acquired in the Agilent Technologies, Inc. dividend reinvestment plan

Read SEC document
March 13, 2018 Filed Sep 24, 2018 13:55 UTC
Gonsalves RodneyV.P., Corporate Controller
GiftCommon Stock 500 $70.68 $35,340.00
Disclosure

SEC source: 0001127602-18-028243 · form4.xml · nonDerivative · entry 1

Gonsalves Rodney · CIK 0001642192 · V.P., Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,924.8411

F1 · balance_after: 236.0015 shares acquired in an Employee Stock Purchase Plan under Section 423 of the Internal Revenue Code of 1986, as amended, in a transaction exempt under Rule 16b-3 and 33.275 shares acquired through the Agilent Technologies, Inc. dividend reinvestment plan.

Read SEC document
March 12, 2018 Filed Mar 14, 2018 13:36 UTC
Kaltenbach PatrickSr Vice President
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 4,875 $0.00 Strike: $41.26 $0.00
Disclosure

SEC source: 0001127602-18-011497 · form4.xml · derivative · entry 3

Kaltenbach Patrick · CIK 0001625775 · Sr Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,292

Underlying: Common Stock · 4,875 shares

Expires 2024-11-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. Stock Plan, in compliance with Rule 16b-3.

F4 · derivative.exercise_date: The option is exercisable in four equal annual installments beginning on the first anniversary of the date of the grant. The first vesting date is stated.

Read SEC document
March 12, 2018 Filed Mar 14, 2018 13:36 UTC
Kaltenbach PatrickSr Vice President
SaleCommon Stock 6,875 $71.38 $490,737.50
Disclosure

SEC source: 0001127602-18-011497 · form4.xml · nonDerivative · entry 2

Kaltenbach Patrick · CIK 0001625775 · Sr Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,547.467

F2 · price: Weighted average sale price was $71.38 with a range of $71.37-$71.38.

Read SEC document
March 12, 2018 Filed Mar 14, 2018 13:36 UTC
Kaltenbach PatrickSr Vice President
Exercise / conversionCommon Stock 4,875 $41.26 $201,142.50
Disclosure

SEC source: 0001127602-18-011497 · form4.xml · nonDerivative · entry 1

Kaltenbach Patrick · CIK 0001625775 · Sr Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,422.467

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: 43.698 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan.

Read SEC document
February 05, 2018 Filed Feb 6, 2018 21:30 UTC Exercise / conversionNon-Employee Director Stock Option (right to buy) · Derivative 15,482 $0.00 Strike: $13.89 $0.00
Disclosure

SEC source: 0001127602-18-004323 · form4.xml · derivative · entry 3

HERBOLD ROBERT J · CIK 0001142632 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Herbold Revoc Trust

Disclosed balance after: 0

Underlying: Common Stock · 15,482 shares

Expires 2018-11-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. 1999 Non-Employee Director Stock Plan.

F2 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
February 05, 2018 Filed Feb 6, 2018 21:30 UTC Exercise / conversionCommon Stock 15,482 $13.89 $215,044.98
Disclosure

SEC source: 0001127602-18-004323 · form4.xml · nonDerivative · entry 1

HERBOLD ROBERT J · CIK 0001142632 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Herbold Revoc Trust

Disclosed balance after: 75,937.19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 29, 2018 Filed Jan 30, 2018 20:40 UTC
McMullen Michael R.Director · CEO and President
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 21,850 $0.00 Strike: $27.19 $0.00
Disclosure

SEC source: 0001127602-18-002956 · form4.xml · derivative · entry 3

McMullen Michael R. · CIK 0001418949 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 21,850 shares

Expires 2021-11-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. Stock Plan, in compliance with Rule 16b-3.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
January 29, 2018 Filed Jan 30, 2018 20:40 UTC
McMullen Michael R.Director · CEO and President
SaleCommon Stock 21,850 $75.00 $1,638,750.00
Disclosure

SEC source: 0001127602-18-002956 · form4.xml · nonDerivative · entry 2

McMullen Michael R. · CIK 0001418949 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 302,836.9846

F1 · date: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 19, 2017.

Read SEC document
January 29, 2018 Filed Jan 30, 2018 20:40 UTC
McMullen Michael R.Director · CEO and President
Exercise / conversionCommon Stock 21,850 $27.19 $594,101.50
Disclosure

SEC source: 0001127602-18-002956 · form4.xml · nonDerivative · entry 1

McMullen Michael R. · CIK 0001418949 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 324,686.9846

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 19, 2018 Filed Jan 23, 2018 15:06 UTC
Tang MichaelSVP, General Counsel, and Sec.
Tax withholdingCommon Stock 487 $73.07 $35,585.09
Disclosure

SEC source: 0001127602-18-002246 · form4.xml · nonDerivative · entry 1

Tang Michael · CIK 0001663020 · SVP, General Counsel, and Sec.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,539.275

F1 · shares: The reporting person surrendered 487 shares to Agilent Technologies, Inc. to satisfy the tax liability on the vesting of restricted stock units in accordance with Rule 16b-3.

Read SEC document
January 18, 2018 Filed Jan 19, 2018 18:54 UTC
McMullen Michael R.Director · CEO and President
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 21,850 $0.00 Strike: $27.19 $0.00
Disclosure

SEC source: 0001127602-18-002166 · form4.xml · derivative · entry 3

McMullen Michael R. · CIK 0001418949 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,850

Underlying: Common Stock · 21,850 shares

Expires 2021-11-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. Stock Plan, in compliance with Rule 16b-3.

F3 · derivative.exercise_date: The option is fully vested and exercisable

Read SEC document
January 18, 2018 Filed Jan 19, 2018 18:54 UTC
McMullen Michael R.Director · CEO and President
SaleCommon Stock 21,850 $72.50 $1,584,125.00
Disclosure

SEC source: 0001127602-18-002166 · form4.xml · nonDerivative · entry 2

McMullen Michael R. · CIK 0001418949 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 302,836.9846

F1 · date: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 19, 2017.

Read SEC document
January 18, 2018 Filed Jan 19, 2018 18:54 UTC
McMullen Michael R.Director · CEO and President
Exercise / conversionCommon Stock 21,850 $27.19 $594,101.50
Disclosure

SEC source: 0001127602-18-002166 · form4.xml · nonDerivative · entry 1

McMullen Michael R. · CIK 0001418949 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 324,686.9846

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 05, 2018 Filed Jan 8, 2018 19:07 UTC
McMullen Michael R.Director · CEO and President
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 43,703 $0.00 Strike: $27.19 $0.00
Disclosure

SEC source: 0001127602-18-001349 · form4.xml · derivative · entry 4

McMullen Michael R. · CIK 0001418949 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,700

Underlying: Common Stock · 43,703 shares

Expires 2021-11-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. Stock Plan, in compliance with Rule 16b-3.

F3 · derivative.exercise_date: The option is fully vested and exercisable

Read SEC document
January 05, 2018 Filed Jan 8, 2018 19:07 UTC
McMullen Michael R.Director · CEO and President
SaleCommon Stock 43,703 $70.00 $3,059,210.00
Disclosure

SEC source: 0001127602-18-001349 · form4.xml · nonDerivative · entry 3

McMullen Michael R. · CIK 0001418949 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 302,836.9846

Read SEC document
January 05, 2018 Filed Jan 8, 2018 19:07 UTC
McMullen Michael R.Director · CEO and President
Exercise / conversionCommon Stock 43,703 $27.19 $1,188,284.57
Disclosure

SEC source: 0001127602-18-001349 · form4.xml · nonDerivative · entry 2

McMullen Michael R. · CIK 0001418949 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 346,539.9846

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 19, 2017.

Read SEC document
December 20, 2017 Filed Jan 8, 2018 19:07 UTC
McMullen Michael R.Director · CEO and President
GiftCommon Stock 1,301.919 $0.00 $0.00
Disclosure

SEC source: 0001127602-18-001349 · form4.xml · nonDerivative · entry 1

McMullen Michael R. · CIK 0001418949 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 302,836.9846

Read SEC document
December 18, 2017 Filed Dec 19, 2017 18:38 UTC
Doak MarkSr. Vice President
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 12,421 $0.00 Strike: $40.80 $0.00
Disclosure

SEC source: 0001127602-17-035082 · form4.xml · derivative · entry 6

Doak Mark · CIK 0001619051 · Sr. Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,421

Underlying: Common Stock · 12,421 shares

Expires 2024-11-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. Stock Plan, in compliance with Rule 16b-3.

F3 · derivative.exercise_date: The option is exercisable in four equal annual installments beginning on the first anniversary of the date of the grant. The first vesting date is stated.

Read SEC document
December 18, 2017 Filed Dec 19, 2017 18:38 UTC
Doak MarkSr. Vice President
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 3,146 $0.00 Strike: $39.12 $0.00
Disclosure

SEC source: 0001127602-17-035082 · form4.xml · derivative · entry 5

Doak Mark · CIK 0001619051 · Sr. Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,146 shares

Expires 2023-11-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. Stock Plan, in compliance with Rule 16b-3.

F2 · derivative.exercise_date: The option is fully vested and exercisable

Read SEC document
December 18, 2017 Filed Dec 19, 2017 18:38 UTC
Doak MarkSr. Vice President
SaleCommon Stock 12,421 $68.00 $844,628.00
Disclosure

SEC source: 0001127602-17-035082 · form4.xml · nonDerivative · entry 4

Doak Mark · CIK 0001619051 · Sr. Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,957.757

Read SEC document
December 18, 2017 Filed Dec 19, 2017 18:38 UTC
Doak MarkSr. Vice President
Exercise / conversionCommon Stock 12,421 $40.80 $506,776.80
Disclosure

SEC source: 0001127602-17-035082 · form4.xml · nonDerivative · entry 3

Doak Mark · CIK 0001619051 · Sr. Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,378.757

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.